Figure 2 | Leukemia

Figure 2

From: Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

Figure 2

(a and b) represent the OS for 92 eligible patients and DFS for 78 patients who achieved a CR, respectively. With a median follow-up of 4.5 years, the 4-year OS for all 92 patients on protocol was 67% (95% CI; 56–76%) and the 4-year DFS was 69% (95% CI; 56–78%) for the 78 patients who achieved a CR. The solid lines represent the Kaplan–Meier estimates, and the dashed lines represent the 95% confidence bands about those estimates. (c and d) Represent OS and DFS by immunophenotype and Philadelphia chromosome status, respectively.

Back to article page